VEGI (1A3) Antibody sc-53975 from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1αTurkish Journal of Medical SciencesJanuary 1, 2024Jing ZHANG, Jiarui KANG, Liyang WU-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted onto nitrocellulose sheets. Proteins were then probed with the VEGI(sc-53975, Santa Cruz, Santa Cruz, CA; dilution 1:1500) or HIF-1α(#36169, Cell Signaling, Beverly, MA; dilution

(2) Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cellsInternational journal of oncologyJuly 1, 2019Kumanishi S, Yamanegi K, Nishiura H, Fujihara Y, Kobayashi K, Nakasho K, Futani H, Yoshiya S.antibody (anti‑human VEGI mouse monoclonal antibody, 2.0 µg/ml; Santa Cruz Biotechnology, Inc.; cat. no. sc‑53975) overnight at room temperature, and then washed three times with washing buffer (PBS containing 0.05%

(3) Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitorInternational journal of oncologyMay 1, 2013Zhang N, Wu P, Shayiremu D, Wu L, Shan H, Ye L, Zhao X, Cai J, Jiang WG, Gong K, et al.

(5) Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitroInternational journal of oncologyDecember 1, 2009Zhang N, Sanders AJ, Ye L, Kynaston HG, Jiang WG.York) were used. Monoclonal mouse anti-human-VEGI was purchased from Santa Cruz Biotechnology, Inc. (SC-53975, CA, USA). RNA isolation and reverse transcription PCR. RNA was isolated using total RNA isolation reagent

VEGI (1A3) Antibody